MART-1:27-35 peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-015014
A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide.
| Identifier | MLC-T-ONC-015014 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015014",
"term": "MART-1:27-35 peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A natural or synthetic peptide cancer vaccine consisting of amino acid residues 27 through 35 of the melanoma-associated antigen MART-1 with potential antineoplastic activity. Vaccination with MART-1:27-35 peptide may induce cytotoxic host immune responses against melanoma cells that express this peptide.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/mart-1-27-35-peptide-vaccine/"
}
Record 10,648 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.